Keyword

PRIMA-1

Description: An experimental anticancer compound that can restore tumor-suppressor activity to mutant p53 and promote cancer-cell death.
OpenAlex ID: keywords/prima-1
2002 · Vladimir J.N. Bykov, Natalia Issaeva, et al. · Nature Medicine · 1,191
2016 · Karin Hientz, André Mohr, et al. · Oncotarget · 660
2009 · Jeremy M.R. Lambert, Petr Gorzov, et al. · Cancer Cell · 654
2017 · Michael J. Duffy, Naoise C. Synnott, et al. · European Journal of Cancer · 395
2003 · Jerry E. Chipuk, Ulrich Maurer, et al. · Cancer Cell · 347
2014 · Johanna Pflaum, Sophie Schlosser, et al. · Frontiers in Oncology · 340
2010 · Marianne Farnebo, Vladimir J.N. Bykov, et al. · Biochemical and Biophysical Research Communications · 304
2018 · Michael J. Duffy, Naoise C. Synnott, et al. · Breast Cancer Research and Treatment · 261
2014 · Michael J. Duffy, Naoise C. Synnott, et al. · Cancer Treatment Reviews · 252
2013 · Christopher D. Wassman, Roberta Baronio, et al. · Nature Communications · 244
2014 · Vladimir J.N. Bykov, Klas G. Wiman · FEBS Letters · 190
2018 · Raman Preet Kaur, Kanika Vasudeva, et al. · Current Pharmaceutical Design · 149
2013 · Manujendra N Saha, Lugui Qiu, et al. · Journal of Hematology & Oncology · 129
2016 · N.C. Synnott, A. Murray, et al. · International Journal of Cancer · 124
2008 · Wenge Wang, Wafik S El-Deiry · Current Opinion in Oncology · 120
2006 · Benjamin Pierre Bouchet, Claude Caron de Fromentel, et al. · Critical Reviews in Oncology/Hematology · 105
2019 · Luciana P. Rangel, Giulia D.S. Ferretti, et al. · Journal of Biological Chemistry · 97
2008 · Nicole Zache, Jeremy M. R. Lambert, et al. · Analytical Cellular Pathology · 90
2021 · Oksana Degtjarik, Dmitrij Golovenko, et al. · Nature Communications · 89
Works count: 212
Citation count: 9,146
Year
Topic
Type